Multiple Differential Networks Strategy Reveals Carboplatin and Melphalan-Induced Dynamic Module Changes in

Cui Chen1, Feng-Wei Ma1, Cui-Yun Du1

  • 1Department of Ophthalmology, Yidu Central Hospital of Weifang, Qingzhou, Shandong, China (mainland).

Insights

This study identifies three dynamic gene modules in retinoblastoma (RB) that change with carboplatin (CAR) and melphalan (MEL) treatment, offering new insights into RB molecular mechanisms and therapy. These findings highlight key molecular pathways affected by chemotherapy in eye cancer.

Area of Science:

  • Oncology
  • Molecular Biology
  • Bioinformatics

Background:

  • Retinoblastoma (RB) is the most common childhood eye malignancy.
  • Understanding RB's molecular progression is crucial for effective treatment strategies.

Purpose of the Study:

  • To investigate dynamic gene module alterations in RB induced by carboplatin (CAR) and melphalan (MEL).
  • To gain systems-level insights into RB progression and chemotherapy response.

Main Methods:

  • Construction of multiple differential co-expression networks (M-DCNs) for RB.
  • Identification of seed genes and module searching to detect dynamic modules (M-DMs).
  • Analysis of module connectivity and dynamic changes using Module Connectivity Dynamic Score (MCDS).

Main Results:

  • Identified 18 two-dimensional modules (2-DMs) and 3 significant dynamic modules (Module 1, Module 2, Module 3).
  • These 3 dynamic modules exhibited significant changes under CAR and MEL treatment conditions.
  • Detailed network properties for each identified dynamic module (nodes, seed genes, edges).

Conclusions:

  • Successfully identified 3 key dynamic modules responsive to CAR and MEL in RB.
  • These findings provide potential molecular targets and insights for improving RB therapy.
  • The study contributes to understanding chemotherapy-induced molecular changes in retinoblastoma.